AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
OLMESARTAN MEDOXOMIL in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| OLMEHEART 20 TABLET, COATED; ORAL | 2020/12.3.5/6021 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
| OLMEHEART 40 TABLET, COATED; ORAL | 2020/12.3.5/6022 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
| OLMEHEART 5 TABLET, COATED; ORAL | 2020/12.3.5/6019 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
| OLMEHEART 10 TABLET, COATED; ORAL | 2020/12.3.5/6020 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
OLMESARTAN MEDOXOMIL — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing OLMESARTAN MEDOXOMIL, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track OLMESARTAN MEDOXOMIL registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.